In the last trading session, 0.13 million shares of the Anebulo Pharmaceuticals Inc (NASDAQ:ANEB) were traded, and its beta was -1.13. Most recently the company’s share price was $1.68, and it changed around $0.04 or 2.44% from the last close, which brings the market valuation of the company to $43.57M. ANEB currently trades at a discount to its 52-week high of $3.30, offering almost -96.43% off that amount. The share price’s 52-week low was $0.80, which indicates that the current value has risen by an impressive 52.38% since then. We note from Anebulo Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 0.11 million shares, with the 3-month average coming to 22.99K.
Anebulo Pharmaceuticals Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended ANEB as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Anebulo Pharmaceuticals Inc is expected to report earnings per share of -0.08 for the current quarter.
Anebulo Pharmaceuticals Inc (NASDAQ:ANEB) trade information
Instantly ANEB has showed a green trend with a performance of 2.44% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.8500 on recent trading dayincreased the stock’s daily price by 9.19%. The company’s shares are currently down -30.58% year-to-date, but still up 34.40% over the last five days. On the other hand, Anebulo Pharmaceuticals Inc (NASDAQ:ANEB) is 16.67% up in the 30-day period. We can see from the shorts that 10758.0 shares have been sold at a short interest cover period of 1.94 day(s).
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 72.0% from its current value. Analyst projections state that ANEB is forecast to be at a low of $6 and a high of $6.
Anebulo Pharmaceuticals Inc (ANEB) estimates and forecasts
Anebulo Pharmaceuticals Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -37.31 percent over the past six months and at a -62.50% annual growth rate that is well below the industry average of 16.70%.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -155.95%.
ANEB Dividends
Anebulo Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in February.
LVW ADVISORS, LLC, with 2.4757% or 0.64 million shares worth $1.75 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
